Thea Pharma
MA - WalthamPharmaceutical
Focus: Thea Pharma is a publicly traded ophthalmic-focused pharmaceutical company headquartered in Waltham, MA, specializing in treatments for glaucoma, dry eye disease, and other eye conditions. The company generates approximately 50% of revenue from BETIMOL (timolol), reflecting a narrow portfolio concentration.
Profile data last refreshed 6h ago · AI intelligence enriched 3d ago
Funding Stage
PUBLIC
Open Jobs
0
About Thea Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Thea Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Thea Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
2 in 5yr
IYUZEH
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$3M Part DDeclining
LOE Approaching
Represents 50% of company revenue; generic competition will accelerate patent cliff risk.
Help build intelligence for Thea Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.